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Background
Lutein and zeaxanthin are carotenoids that are selec-
tively taken up into the macula of the eye, where they
may protect against development of age-related macular
degeneration (AMD). Past studies have reported an age-
dependent decline of macular pigment optical density
(MPOD) in patients with AMD. In the present study we
investigated the age-dependence of MPOD and melato-
nin using spectral fundus reflectance. In addition, we
hypothesized that patients with AMD have a reduced
MPOD as compared to healthy controls.
Methods
A total of 82 healthy subjects and 96 patients with AMD
were included in this study. The healthy control subjects
showed a wide range of ages (mean 51.6 years, range
21–79 years). Patients with AMD were significantly
older (mean 71.2 years, range 50–89 years). Spectral
fundus reflectance of the fovea was measured in a 2.3°
detection field with a custom-built fundus reflectometer.
Calculation of MP and melanin optical density was
based on a previously published fundus reflectance
model [1].
Results
No age dependence of MPOD (r = −0.15) or melatonin
optical density (r = 0.08) was found in the healthy con-
trol group. Patients with AMD, however, showed a
reduced MPOD (0.35 ± 0.12) as compared to the
healthy control group (0.39 ± 0.12, p = 0.013). No
significant difference in melatonin optical density was
observed between the two groups (AMD: 1.05 ± 0.24;
healthy controls: 1.03 ± 0.24, p = 0.58).
Conclusions
A variety of studies showing a decline in MPOD with
age are based on heterochromatic flickerphotometry
data. By contrast, most data indicating no change in
MPOD with age are based on the use of objective tech-
nology such as fundus reflectance or autofluoresence.
The present study confirms the latter studies. In addi-
tion, the data of the present study indicate that patients
with AMD have reduced MPOD, but not melatonin
optical density. This supports the hypothesis that
reduced macular pigment is associated with AMD.
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